17-alpha-hydroxyprogesterone has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajpai, A; Kabra, M; Menon, PS; Singhal, T | 1 |
| Stewart, C; Weissman, DE | 1 |
2 other study(ies) available for 17-alpha-hydroxyprogesterone and Brain Neoplasms
| Article | Year |
|---|---|
CNS germinoma in a boy with simple virilizing 21-hydroxylase deficiency and precocious puberty.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Brain Neoplasms; Child; Fatal Outcome; Germinoma; Glucocorticoids; Humans; Male; Mineralocorticoids; Puberty, Precocious; Tomography, X-Ray Computed | 2002 |
Experimental drug therapy of peritumoral brain edema.
Topics: 17-alpha-Hydroxyprogesterone; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Edema; Brain Neoplasms; Dexamethasone; Hydrocortisone; Hydroxyprogesterones; Male; Neovascularization, Pathologic; Rabbits | 1988 |